Contract HT942525AE002
Edge Biosystems Inc · Department Of Defense · August 25, 2025
Edge Biosystems Inc was awarded a federal contract by Department Of Defense (Defense Health Agency) on August 25, 2025 for an undisclosed amount of work in in-vitro diagnostic substance manufacturing. It uses order dependent (idv allows pricing arrangement to be determined separately for each order) contract pricing. If all options are exercised, the contract could reach $2.90 million.
Contract details
- PIID
- HT942525AE002
- Award type
- —
- Pricing
- Order Dependent (Idv Allows Pricing Arrangement To Be Determined Separately For Each Order)
- NAICS
- 325413 · In-Vitro Diagnostic Substance Manufacturing
- Product / service
- Laboratory Equipment And Supplies
- First action
- August 25, 2025
Description
DYE TERMINAL REMOVAL PLATES
Modification timeline
-
August 25, 2025Base award$0
Similar contracts
| Recipient | Agency | Date | Obligated |
|---|---|---|---|
| Diasorin Inc | Department Of Defense | December 31, 2025 | $518.8K |
| Bloodworks | Department Of Defense | December 31, 2025 | $160.2K |
| Sl Meditech Co. | Department Of Defense | December 31, 2025 | $151.6K |
| Alba Bioscience, Inc. | Department Of Defense | December 31, 2025 | $163.2K |
| Werfen USA Llc | Department Of Defense | December 31, 2025 | $18.1K |
| Immucor Inc | Department Of Defense | December 31, 2025 | $154.2K |
Top contractors in NAICS 325413
Lifetime obligated dollars across all federal contracts in this NAICS code.
| # | Contractor | Contracts | Obligated |
|---|---|---|---|
| 1 | Biomerieux Inc | 182 | $25.50M |
| 2 | Cepheid | 114 | $20.70M |
| 3 | Roche Diagnostics Corporation | 125 | $13.00M |
| 4 | Quest Diagnostics Incorporated | 8 | $4.31M |
| 5 | Hologic Sales And Service, Llc | 39 | $3.88M |
| 6 | Beckman Coulter, Inc | 28 | $3.40M |
| 7 | Fisher Scientific Company L.L.C. | 52 | $3.04M |
| 8 | Werfen USA Llc | 91 | $2.75M |
| 9 | Diasorin Inc | 21 | $2.74M |
| 10 | Abbott Laboratories Inc. | 10 | $2.69M |
Track this on BesaGov
Get a free weekly email when this changes — new awards, new sub-awards, new opportunities. No login required.
Continue learning
Keep researching
Frequently asked questions
What is contract HT942525AE002?
Contract HT942525AE002 is a federal contract awarded to Edge Biosystems Inc by Department Of Defense on August 25, 2025 for an undisclosed amount of work classified under IN-VITRO DIAGNOSTIC SUBSTANCE MANUFACTURING. It has been modified 0 times since the base award.
Who won contract HT942525AE002?
Edge Biosystems Inc won contract HT942525AE002 from Department Of Defense.
How much is contract HT942525AE002 worth?
Contract HT942525AE002 has obligated $0 to date but carries a potential ceiling of $2.90 million if fully funded and all options are exercised.